Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging. Nowhere is that more evident than in the biopharma space, which is contending with multiple factors including a new administration in the US, new regulatory requirements in the EU, supply chain issues, and an uncertain economy. Despite these obstacles, however,…...
Read MoreTop Stories
Science, AI, and Human Ingenuity Converge to
Today, we're witnessing an unprecedented convergence of...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Leveraging Social Media to Transform Medical
This whitepaper explores the role of social media in...
Filter
Rare Diseases – An Evolving Medical Communications Landscape
A disease is considered rare when it affects fewer than 1 in 2,000 people. However...
The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans
In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant...
It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
Improving Health Outcomes by Empowering Patients: The Future Is Here
Empowering patients and involving them as key stakeholders in the drug development lifecycle can help...
The Quest for Omnichannel: Is Medical Affairs Ready?
Commercial and Medical Affairs must partner with each other to achieve the real benefits of...
Diversity, Equity, and Inclusion: The Fuel That Drives Business Forward
Ensuring that your organization embraces DE & I training is important for cultivating a strong...